First International Workshop on HIV-1 Persistence During Therapy.
Center for Human Virology and Biodefense, Philadelphia, Pennsylvania, USA.
Roger
R
Pomerantz
Alain
A
Lafeuillade
D044966:Anti-Retroviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D015704:CD4 Antigens / Q000097:blood; D018076:DNA, Complementary / Q000187:drug effects; D004279:DNA, Viral / Q000187:drug effects; D016355:Genes, pX / Q000187:drug effects; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D012333:RNA, Messenger / Q000187:drug effects; D014766:Viremia / Q000517:prevention & control / Q000821:virology
D044966:Anti-Retroviral Agents; D015704:CD4 Antigens; D018076:DNA, Complementary; D004279:DNA, Viral; D012333:RNA, Messenger